NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Specialty pharmaceutical company Horizon Pharma Plc (HZNP.O) has hired Bank of America Corp (BAC.N) to help it explore selling a significant equity stake to an investor that would bolster its balance sheet, people familiar with the matter said on Monday. It is not clear how Horizon would use the proceeds,…

news

Mylan N.V. announced that it has launched dutasteride capsules, 0.5 mg -- the generic version of GlaxoSmithKline’s GSK Avodart -- after receiving an FDA approval for an abbreviated New Drug Application (ANDA) of the drug. Avodart is approved as monotherapy for the treatment of symptomatic benign prostatic hyperplasia (BPH) in…

news

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended six new medicines, including one advanced therapy medicinal product (ATMP), for approval at its June meeting. The CHMP recommended granting a conditional marketing authorisation for the ATMP Zalmoxis as an adjunctive, or add-on, treatment for adult patients…

news

Aiming to stop the illegal diversion of certain chemical formulations used to prepare drugs, such as heroin and 'methamphetamine', the Narcotics Control Bureau (NCB) has planned to sensitize the pharmaceutical industry to curb the practice. Apart from concern about abuse of chemicals by drug mafia to manufacture psychotropic drugs, also…

news

A high-ranking Senate Democrat is pushing for more answers on why doctors and patient advocates with financial ties to the pharmaceutical industry came to serve on a panel that advises the federal government on pain issues. Sen. Ron Wyden says he is "even more concerned" about these apparent conflicts of…

news

Britain's vote to leave the European Union spells regulatory uncertainty for drug companies, with the London-based European Medicines Agency (EMA), which approves treatments for all EU countries, expected to have to relocate. The association of Germany's pharmaceuticals industry said on Friday that Europe's equivalent of the U.S. Food and Drug…

news

Boston Biomedical announces first orphan drug designation for Napabucasin in gastric/gej cancer. Boston Biomedical - Napabucasin currently investigated in a phase iii clinical trial in combination with paclitaxel in patients with advanced gastric and gej cancer.   Source : reuters.com

news

Astrazeneca Plc Says would have been better for uk to remain in eu, will now be protracted period of transition. Astrazeneca says aims to safeguard competitiveness of life sciences industry and speed of patient access to innovative medicines.   Source : reuters.com

news

India's largest drugmaker Sun Pharmaceutical Industries is banking on the launch of newer and more complex products to offset rising competition in its lucrative U.S. dermatology business, its U.S. chief said. The world's fifth-largest maker of generic drugs was the first among its Indian peers to enter the roughly $5…

news

Palatin Technologies On june 20, 2016 co entered commercial supply agreement with unit of catalent pharma solutions with an effective date of june 10. Sec filing. Palatin intends to engage third parties to provide catalent with a supply of bremelanotide and disposable auto-injector device. All patients are projected to complete…